vimarsana.com

Latest Breaking News On - பிலிப் மார்கோ - Page 1 : vimarsana.com

The U.S. may be ready to see cicadas gone, but this French village has a statue, a song and ceramics in their honor

The U.S. may be ready to see cicadas gone, but this French village has a statue, a song and ceramics in their honor
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

Le-castellet
Provence-alpes-côd-azur
France
Washington
United-states
Le-beausset
French
Yves-pujol
Marie-christine-fenot
Philippe-marco
France-national-museum-of-natural-history
Youtube

Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology

Press release content from Business Wire. The AP news staff was not involved in its creation. Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology February 1, 2021 GMT ST. PAUL, Minn. (BUSINESS WIRE) Feb 1, 2021 Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs). This partnership brings together CSI’s leadership in the treatment of calcified arterial lesions with Dr. Philippe Marco, a pioneer in the successful development of several drug-coated devices. DCBs are a widely accepted percutaneous interventional treatment option for femoro-popliteal lesions in patients with peripheral artery disease (PAD), and are increasingly recognized for their potential in complex coronary artery disease (CAD), including their use in in-stent resteno

California
United-states
Jack-nielsen
Philippe-marco
Ryan-egeland
Perclose-inc
Chansu-vascular-technologies
Cardiovascular-systems-inc
Twitter
Medtronic
Nasdaq
Affairs-for-abbott-vascular

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.